TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354 | -99.9% | 42,363 | +234.5% | 0.01% | +60.0% |
| Q4 2021 | $241,000 | -43.0% | 12,666 | -0.4% | 0.01% | -44.4% |
| Q3 2021 | $423,000 | +386.2% | 12,716 | +27.2% | 0.01% | +350.0% |
| Q2 2019 | $87,000 | -28.1% | 10,000 | -33.3% | 0.00% | -33.3% |
| Q1 2019 | $121,000 | -13.6% | 15,000 | -50.0% | 0.00% | -57.1% |
| Q4 2016 | $140,000 | -39.7% | 30,000 | 0.0% | 0.01% | -50.0% |
| Q3 2016 | $232,000 | +25.4% | 30,000 | -2.0% | 0.01% | 0.0% |
| Q2 2016 | $185,000 | -57.5% | 30,600 | -40.0% | 0.01% | -26.3% |
| Q1 2016 | $435,000 | -28.5% | 51,000 | 0.0% | 0.02% | -54.8% |
| Q4 2015 | $608,000 | +18.3% | 51,000 | 0.0% | 0.04% | +82.6% |
| Q3 2015 | $514,000 | +3.2% | 51,000 | +70.0% | 0.02% | +15.0% |
| Q2 2015 | $498,000 | -19.5% | 30,000 | -25.0% | 0.02% | -25.9% |
| Q1 2015 | $619,000 | +8.6% | 40,000 | +11.1% | 0.03% | +35.0% |
| Q4 2014 | $570,000 | +52.8% | 36,000 | +2.9% | 0.02% | +122.2% |
| Q3 2014 | $373,000 | +58.7% | 35,000 | +40.0% | 0.01% | +80.0% |
| Q2 2014 | $235,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |